Best paper NASS 2013: Link-N can stimulate proteoglycan synthesis in the degenerated human intervertebral discs

European Cells and Materials

Volumn 26, Issue , 2013, Pages 107-119

  Gawri, Rahul ^a,b,c   Antoniou, John ^b,c   Ouellet, Jean ^a,c   Awwad, Waleed ^c   Steffen, Thomas ^a,c   Roughley, Peter ^c,d   Haglund, Lisbet ^a,c   Mwale, Fackson ^b,c  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Bioactive peptides; Biological repair; Human intervertebral disc degeneration; Link N; Organ culture; Proteoglycans; Regeneration; Tissue engineering

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; ANABOLIC AGENT; COLLAGENASE 3; INTERLEUKIN 1; LINK N PEPTIDE; PROTEINASE; STROMELYSIN; UNCLASSIFIED DRUG;

ADAMTS 4 GENE; ADAMTS 5 GENE; ADOLESCENT; ADULT; AGED; AGGRECAN GENE; ANIMAL CELL; ARTICLE; BONE CELL; CELL VIABILITY; CLINICAL EVALUATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERVERTEBRAL DISK DEGENERATION; MALE; MMP 13 GENE; MMP 3 GENE; NONHUMAN; NUCLEUS PULPOSUS; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; THORACOLUMBAR SPINE; UPREGULATION;

ADAM PROTEINS; ADOLESCENT; ADULT; AGED; AGGRECANS; ANIMALS; CATTLE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; INTERLEUKIN-1; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RNA, MESSENGER;

EID: 84884676763     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v026a08     Document Type: Article

References (55)

1. Abbott RD, Purmessur D, Monsey RD, Brigstock DR, Laudier DM, Iatridis JC (2013) Degenerative grade affects the responses of human nucleus pulposus cells to link-N, CTGF, and TGFbeta3. J Spinal Disord Tech 26: E86-94.
2. Akyol S, Eraslan BS, Etyemez H, Tanriverdi T, Hanci M (2010) Catabolic cytokine expressions in patients with degenerative disc disease. Turk Neurosurg 20: 492-499.
3. Alini M, Roughley PJ, Antoniou J, Stoll T, Aebi M (2002) A biological approach to treating disc degeneration: not for today, but maybe for tomorrow. Eur Spine J 11 Suppl 2: S215-220.
4. Anderson DG, Risbud MV, Shapiro IM, Vaccaro AR, Albert TJ (2005) Cell-based therapy for disc repair. Spine J 5: 297S-303S.
5. Antoniou J, Wang HT, Alaseem AM, Haglund L, Roughley PJ, Mwale F (2012) The effect of Link-N on differentiation of human bone marrow-derived mesenchymal stem cells. Arthritis Res Ther 14: R267.
6. Boyd LM, Carter AJ (2006) Injectable biomaterials and vertebral endplate treatment for repair and regeneration of the intervertebral disc. Eur Spine J 15 Suppl 3: S414-421.
7. Chadderdon RC, Shimer AL, Gilbertson LG, Kang JD (2004) Advances in gene therapy for intervertebral disc degeneration. Spine J 4: 341S-347S.
8. Chan SC, Gantenbein-Ritter B (2012a) Intervertebral disc regeneration or repair with biomaterials and stem cell therapy--feasible or fiction? Swiss Med Wkly 142: w13598.
9. Chan SC, Gantenbein-Ritter B (2012b) Preparation of intact bovine tail intervertebral discs for organ culture. J Vis Exp, in press.
10. Chiba K, Andersson GB, Masuda K, Momohara S, Williams JM, Thonar EJ (1998) A new culture system to study the metabolism of the intervertebral disc in vitro. Spine 23: 1821-1827; discussion 1828.
11. Chou AI, Reza AT, Nicoll SB (2008) Distinct intervertebral disc cell populations adopt similar phenotypes in three-dimensional culture. Tissue Eng Part A 14: 2079-2087.
12. Chung SA, Khan SN, Diwan AD (2003) The molecular basis of intervertebral disk degeneration. Orthop Clin North Am 34: 209-219.
13. Cuellar JM, Golish SR, Reuter MW, Cuellar VG, Angst MS, Carragee EJ, Yeomans DC, Scuderi GJ (2010) Cytokine evaluation in individuals with low back pain using discographic lavage. Spine J 10: 212-218.
14. Dagenais S, Caro J, Haldeman S (2008) A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 8: 8-20.
15. Donohue PJ, Jahnke MR, Blaha JD, Caterson B (1988) Characterization of link protein(s) from human intervertebral-disc tissues. Biochem J 251: 739-747.
16. Engel CC, Von Korff M, Katon WJ (1996) Back pain in primary care: predictors of high health-care costs. Pain 65: 197-204.
17. Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA (2002) Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol 196: 374-379.
18. Frymoyer JW, Cats-Baril WL (1991) An overview of the incidences and costs of low back pain. Orthop Clin North Am 22: 263-271.
19. Gawri R, Mwale F, Ouellet J, Roughley PJ, Steffen T, Antoniou J, Haglund L (2011) Development of an organ culture system for long-term survival of the intact human intervertebral disc. Spine 36: 1835-1842.
20. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, Poole AR (1994) Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 93: 1722-1732.
21. Illien-Junger S, Gantenbein-Ritter B, Grad S, Lezuo P, Ferguson SJ, Alini M, Ito K (2010) The combined effects of limited nutrition and high-frequency loading on intervertebral discs with endplates. Spine 35: 1744-1752.
22. Imai Y, Miyamoto K, An HS, Thonar EJ, Andersson GB, Masuda K (2007a) Recombinant human osteogenic protein-1 upregulates proteoglycan metabolism of human anulus fibrosus and nucleus pulposus cells. Spine 32: 1303-1309; discussion 1310.
23. Imai Y, Okuma M, An HS, Nakagawa K, Yamada M, Muehleman C, Thonar E, Masuda K (2007b) Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine 32: 1197-1205.
24. Jim B, Steffen T, Moir J, Roughley P, Haglund L (2011) Development of an intact intervertebral disc organ culture system in which degeneration can be induced as a prelude to studying repair potential. Eur Spine J 20: 1244-1254.
25. Kandel R, Roberts S, Urban JP (2008) Tissue engineering and the intervertebral disc: the challenges. Eur Spine J 17 Suppl 4: 480-491.
26. Korecki CL, MacLean JJ, Iatridis JC (2008) Dynamic compression effects on intervertebral disc mechanics and biology. Spine 33: 1403-1409.
27. Kulkarni AG, Hee HT (2006) Adjacent level discitis after anterior cervical discectomy and fusion (ACDF): a case report. Eur Spine J 15 Suppl 5: 559-563.
28. Lee CR, Iatridis JC, Poveda L, Alini M (2006) In vitro organ culture of the bovine intervertebral disc: effects of vertebral endplate and potential for mechanobiology studies. Spine 31: 515-522.
29. Lee S, Moon CS, Sul D, Lee J, Bae M, Hong Y, Lee M, Choi S, Derby R, Kim BJ, Kim J, Yoon JS, Wolfer L, Kim J, Wang J, Hwang SW, Lee SH (2009) Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem 42: 1504-1511.
30. Le Maitre CL, Freemont AJ, Hoyland JA (2005) The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7: R732-745.
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods 25: 402-408.
32. Lund T, Oxland TR (2011) Adjacent level disk disease-is it really a fusion disease? Orthop Clin North Am 42: 529-541, viii.
33. Luo X, Pietrobon R, Sun SX, Liu GG, Hey L (2004) Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine 29: 79-86.
34. Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A (2000) Low back pain in relation to lumbar disc degeneration. Spine 25: 487-492.
35. Maldonado BA, Oegema TR Jr (1992) Initial characterization of the metabolism of intervertebral disc cells encapsulated in microspheres. J Orthop Res 10: 677-690.
36. Malemud CJ, Killeen W, Hering TM, Purchio AF (1991) Enhanced sulfated-proteoglycan core protein synthesis by incubation of rabbit chondrocytes with recombinant transforming growth factor-beta 1. J Cell Physiol 149: 152-159.
37. Mapel DW, Shainline M, Paez K, Gunter M (2004) Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J Rheumatol 31: 573-583.
38. Masuda K (2008) Biological repair of the degenerated intervertebral disc by the injection of growth factors. Eur Spine J 17 Suppl 4: 441-451.
39. Masuda K, Oegema TR Jr, An HS (2004) Growth factors and treatment of intervertebral disc degeneration. Spine 29: 2757-2769.
40. Masuda K, Imai Y, Okuma M, Muehleman C, Nakagawa K, Akeda K, Thonar E, Andersson G, An HS (2006) Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine 31: 742-754.
41. McKenna LA, Liu H, Sansom PA, Dean MF (1998) An N-terminal peptide from link protein stimulates proteoglycan biosynthesis in human articular cartilage in vitro. Arthritis Rheum 41: 157-162.
42. Melching LI, Roughley PJ (1985) The role of link protein in mediating the interaction between hyaluronic acid and newly secreted proteoglycan subunits from adult human articular cartilage. J Biol Chem 260: 16279-16285.
43. Mwale F, Demers CN, Petit A, Roughley P, Poole AR, Steffen T, Aebi M, Antoniou J (2003) A synthetic peptide of link protein stimulates the biosynthesis of collagens II, IX and proteoglycan by cells of the intervertebral disc. J Cell Biochem 88: 1202-1213.
44. Mwale F, Masuda K, Pichika R, Epure LM, Yoshikawa T, Hemmad A, Roughley PJ, Antoniou J (2011) The efficacy of Link-N as a mediator of repair in a rabbit model of intervertebral disc degeneration. Arthritis Res Ther 13: R120.
45. Petit A, Yao G, Rowas SA, Gawri R, Epure L, Antoniou J, Mwale F (2011) Effect of synthetic Link-N peptide on the expression of type I and type II collagens in human intervertebral disc cells. Tissue Eng Part A 17: 899-904.
46. Roughley PJ (2004) Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine 29: 2691-2699.
47. Roughley P, Hoemann C, DesRosiers E, Mwale F, Antoniou J, Alini M (2006a) The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials 27: 388-396.
48. Roughley PJ, Melching LI, Heathfield TF, Pearce RH, Mort JS (2006b) The structure and degradation of aggrecan in human intervertebral disc. Eur Spine J 15 Suppl 3: S326-332.
49. Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, Bullock R, Isaacs RE, Brown C, Richardson WJ (2010) Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum 62: 1974-1982.
50. Van Beuningen HM, Van der Kraan PM, Arntz OJ, Van den Berg WB (1994) In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences. Ann Rheum Dis 53: 593-600.
51. Wang J, Markova D, Anderson DG, Zheng Z, Shapiro IM, Risbud MV (2011) TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem 286: 39738-39749.
52. Wang Z, Hutton WC, Yoon ST (2013) ISSLS prize winner: the effect of Link protein peptide (LPP) on human intervertebral disc cells. Spine 38: 1501-1507.
53. Woods BI, Vo N, Sowa G, Kang JD (2011) Gene therapy for intervertebral disk degeneration. Orthop Clin North Am 42: 563-574, ix.
54. Yoon ST (2005) Molecular therapy of the intervertebral disc. Spine J 5: 280S-286S.
55. Zhao CQ, Wang LM, Jiang LS, Dai LY (2007) The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev 6: 247-261.